This daily electronic briefing delivers coverage of what’s happening on
Capitol Hill and at the FDA, FTC, HHS, NIH and other key agencies and
decision-making bodies that affect the pharmaceutical industry. Each
issue gives you hard reporting on top issues, such as drug-safety
oversight, clinical trial registries, adverse event reporting and
warning letters. Written by FDAnews’ veteran staff of reporters, you
get the news as it happens with the added perspective that only
seasoned reporters can provide. It’s the fastest, most reliable way to
make sure you’re an industry expert.
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today.Read More
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today.Read More
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not!